AI Airlock
-
MHRA Expedites Approval for AI in Patient Care
The UK’s MHRA is accelerating the evaluation of AI tools to revolutionize healthcare, aiming to drastically reduce medical test result waiting times through its ‘AI Airlock’ program. Seven novel AI technologies are being rigorously assessed to address healthcare challenges, potentially speeding up cancer diagnosis and improving detection of genetic eye diseases. The program provides a secure environment for testing, informing the MHRA’s evolving AI regulatory framework and the National Commission into the Regulation of AI in Healthcare. This initiative emphasizes safe and effective AI adoption within the NHS.
